EPO906 Therapy in Patients With Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

January 31, 2002

Primary Completion Date

January 31, 2004

Study Completion Date

January 31, 2004

Conditions
Prostatic Neoplasms
Interventions
DRUG

epothilone b

Trial Locations (5)

21201

University of Maryland - Greenbaum Cancer Center, Baltimore

90813

Pacific Shores Medical Group, Long Beach

94115

California Pacific Medical Center, San Francisco

98109

Seattle Cancer Care Alliance, Seattle

08901

Cancer Institute of New Jersey (CINJ), New Brunswick

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY